다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
NeuBase Therapeutics Inc (NBSE)
NeuBase Therapeutics Inc (NBSE) 뉴스

NBSE

NeuBase Therapeutics (NBSE)

NeuBase Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NBSE

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	05:59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/05/16	23:07	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/05/14	05:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/05/06	20:30	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/04/06	05:05	GlobeNewswire Inc.	NeuBase Therapeutics Announces Receipt of Notice from Nasdaq	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/03/08	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/02/24	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/01/26	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/01/17	20:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/12/28	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/12/28	20:15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/12/22	20:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/11/27	23:00	GlobeNewswire Inc.	Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/11/10	06:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/11/07	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/11/07	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/10/20	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/10/18	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/30	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/21	09:42	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/21	06:28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/19	05:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/19	05:20	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/19	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/14	19:03	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/13	06:20	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/12	06:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/08	20:00	GlobeNewswire Inc.	NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/08	06:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NBSE	NeuBase Therapeutics Inc
2023/09/06	23:00	PR Newswire (US)	SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE	NASDAQ:NBSE	NeuBase Therapeutics Inc

검색 관련기사 보기:NASDAQ:NBSE

1 2 3 4 5 6 다음 >>

Intesa Sanpaolo

Lakeshore Acquisition II

ELETG320 Ex:31,6

Vontobel Financial Produ...

코오롱플라스틱

Vontobel Financial Produ...

Alpha Healthcare Acquisi...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관